Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $113,670 - $133,200
4,500 New
4,500 $125,000
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $69,950 - $90,857
2,677 Added 261.68%
3,700 $106,000
Q3 2023

Oct 31, 2023

BUY
$32.09 - $37.51 $32,828 - $38,372
1,023 New
1,023 $33,000
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $40,205 - $52,483
963 Added 424.23%
1,190 $60,000
Q3 2022

Oct 27, 2022

SELL
$43.76 - $53.42 $50,586 - $61,753
-1,156 Reduced 83.59%
227 $13,000
Q2 2022

Jul 21, 2022

BUY
$46.53 - $55.17 $44,622 - $52,908
959 Added 226.18%
1,383 $82,000
Q1 2022

Apr 15, 2022

SELL
$45.75 - $56.69 $960 - $1,190
-21 Reduced 4.72%
424 $22,000
Q4 2021

Feb 04, 2022

SELL
$41.32 - $61.25 $65,202 - $96,652
-1,578 Reduced 78.0%
445 $26,000
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $73,005 - $93,781
-1,860 Reduced 47.9%
2,023 $87,000
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $131,394 - $148,848
3,659 Added 1633.48%
3,883 $152,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $216,278 - $243,918
-6,458 Reduced 96.65%
224 $8,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $223,646 - $284,385
6,682 New
6,682 $246,000
Q1 2020

Apr 21, 2020

SELL
$27.03 - $38.62 $137,042 - $195,803
-5,070 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $97,772 - $110,959
2,970 Added 141.43%
5,070 $199,000
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $87,723 - $113,751
-2,700 Reduced 56.25%
2,100 $75,000
Q2 2019

Jul 31, 2019

BUY
$36.98 - $41.52 $177,503 - $199,296
4,800 New
4,800 $208,000
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $23,625 - $25,956
-630 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $24,236 - $27,631
630 New
630 $27,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mizuho Securities Co. Ltd. Portfolio

Follow Mizuho Securities Co. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Co. Ltd. with notifications on news.